Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

114 results for Pharmaceuticals
CLEAR ALL
Actylis
Excipient developed for pharmaceutical applications.  Benefits:
  • Possesses characteristic aromatic odor
  • Assay: 89.86 %
  • Complies with USP specifications
Actylis
Excipient developed for solid and semi-solid dosage formulations. It is used to adjust pH.Benefits:
  • Complies with USP-NF specifications
Actylis
Excipient developed for pharmaceutical applications. It is used to adjust pH and as an antioxidant in solid and semi-solid dosage formulations.Benefits:
  • Complies with USP-NF specifications
Actylis
Excipient designed for pharmaceutical applications. It is used to adjust pH in solid and semi-solid dosage formulations.Benefits:
  • Complies with USP, Ph Eur and CP specifications
Actylis
Excipient suitable for pharmaceutical applications. It is used as a preservative in solid and semi-solid dosage forms. Benefits:
  • Complies with USP specifications
Actylis
Excipient used for pharmaceutical applications. It is used as preservative in solid and semi-solid dosage forms. Benefits:
  • Complies with USP and Ph Eur specifications
Actylis
Preservative specially developed for injectable formulations, solid and semi-solid dosage forms.Benefits:
  • DMF Filed
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc) 
Actylis
Excipient for pharmaceutical applications.Benefits:
  • Effloresces in warm, dry air. Its solutions are alkaline to phenolphthalein TS, a 0.1 M solution having a pH of about 9
  • Freely soluble in water, very slightly soluble in alcohol
Actylis
Coating agent developed for solid and semi-solid dosage forms.Benefits:
  • Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
Actylis
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20190000639
Actylis
Solvent/ Co-solvent and chelating agent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
Actylis
Solvent and permeation enhancer designed for transdermal patches and oral solid dosage formulas.Benefits:
  • Highly pure, improves drug efficacy by increasing skin permeation
  • Compliant with USP and Ph. Eur
Actylis
Excipient developed for pharmaceutical applications. It functions as a chelating agent in solid and semi-solid dosage forms.Benefits:
  • Complies with USP and Ph. Eur.
Actylis
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
  • It maintains low level of endotoxins with the bioburden limits- BET/MLT
  • Controlled metallic impurities
  •  Developed for…
Actylis
Antioxidant for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189